Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
December 12, 2017
Ohr Pharmaceutical to Announce Fiscal Fourth Quarter & Year End 2017 Results on Friday, December 15
Ohr Pharmaceutical, Inc. (OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that it will report financial results for its fiscal ...
December 12, 2017
VBI Vaccines to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference
CAMBRIDGE, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (VBV.TO) (VBI) today announced that Jeff Baxter, President and CEO, will present at ...
December 12, 2017
Soleno Therapeutics Announces $15 Million Private Placement
REDWOOD CITY, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
December 12, 2017
Rockwell Medical Signs Exclusive License Agreement with Quimica Europea to Commercialize Triferic® in Peru
WIXOM, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), announced today that it has signed an exclusive license and manufacturing supply agreement ...
December 12, 2017
UroGen Pharma Expands Clinical Development Leadership Team
RA'ANANA, Israel and NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) --  UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in ...
December 12, 2017
Acer Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
NEWTON, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
December 11, 2017
Minerva Neurosciences Names Richard Russell President
WALTHAM, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
December 11, 2017
Aptose Presents New Preclinical Data on CG’806 pan-FLT3/pan-BTK Inhibitor at ASH 59th Annual Meeting
SAN DIEGO and TORONTO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO) today announced the presentation of preclinical data from research led ...
December 11, 2017
Investors Initiate Tender Offer to Take BioCanCell Private Ahead of Planned Fundraising Round
JERUSALEM, Dec. 11, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to ...
December 11, 2017
Acer Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
NEWTON, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
December 11, 2017
Achaogen Appoints Blake Wise Chief Executive Officer
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company discovering and developing innovative antibacterials addressing multi-drug resistant ...
December 11, 2017
Prometic's PBI-4050 Receives Promising Innovative Medicine (PIM) Designation From The UK MHRA In The Treatment Of Idiopathic Pulmonary Fibrosis
LAVAL, QC, Dec. 11, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic) announced today that its orally-active drug candidate, PBI-4050, has been issued a Promising Innovative ...
December 11, 2017
ADMA Files Biologics License Application For Its Third Plasma Collection Center
RAMSEY, N.J. and MARIETTA, Ga., Dec. 11, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company ...
December 11, 2017
Reata Pharmaceuticals, Inc. Presents Interim Phase 1b Data for Omaveloxolone in the Treatment of Unresectable or Metastatic Melanoma
IRVING, Texas, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced the presentation of interim ...
December 11, 2017
Catalyst Biosciences Announces Interim Phase 1/2 CB 2679d/ISU304 Results at the American Society of Hematology Conference
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
December 11, 2017
Altimmune Submits Investigational New Drug Application for NasoShield in Preparation for its Phase 1 Trial
GAITHERSBURG, Md., Dec. 11, 2017 (GLOBE NEWSWIRE) --  Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced the Company has submitted an Investigational New Drug ...
December 11, 2017
Caelum Biosciences Announces Positive Phase 1a/1b Data Demonstrating CAEL-101 (mAb 11-1F4) Improves Organ Function in AL Amyloidosis
NEW YORK, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (FBIO) Company focused on developing treatments for rare and ...
December 11, 2017
German Federal Ministry of Education and Research to Fund the CytoSorb® Endocarditis REMOVE Trial
MONMOUTH JUNCTION, N.J., Dec. 11, 2017 /PRNewswire/ -- CytoSorbents Corporation(CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in critically-ill and cardiac surgery patients around ...
December 11, 2017
Minerva Neurosciences Elects William Doyle and Hans Peter Hasler to Board of Directors
WALTHAM, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
December 11, 2017
Rexahn Pharmaceuticals Presents New Preclinical Data on Supinoxin™ at the 2017 San Antonio Breast Cancer Symposium
ROCKVILLE, Md., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment ...
Page 118 of 162